The power of creatine plus resistance training for healthy aging: enhancing physical vitality and cognitive function
Diego A. Bonilla,Jeffrey R. Stout,Darren G. Candow,José Daniel Jiménez-García,Luis M. Gómez-Miranda,Melinna Ortiz-Ortiz,Scott C. Forbes,Sergej M. Ostojic,Salvador Vargas-Molina,Richard B. Kreider
DOI: https://doi.org/10.3389/fphys.2024.1496544
IF: 4
2024-12-04
Frontiers in Physiology
Abstract:Sarcopenia is generally defined as an age-related musculoskeletal disease characterized by the reductions in muscle strength, lean/muscle mass (quality) and functional ability leading to various adverse health outcomes, including impaired physical function and reduced quality of life (1). Sarcopenia is also associated with cognitive decline in older adults (2). As sarcopenia is a potentially reversible condition whose prevalence increases with age, several non-pharmacological strategies have been developed to counteract its progression in older adults (3,4).Sedentary or and physically inactive older adults exhibit a reduced myofibrillar protein proteinsynthetic synthesis response to dietary protein intake, which significantly accelerates the progression of sarcopenia (5). This issue is further exacerbated in obese elderly populations. Age-related muscle 'anabolic resistance' becomes particularly pronounced in response to low or moderate protein intake, a dietary pattern commonly observed in older individuals (6). It is now recognized that a daily intake of at least 1.0 grams of protein per kg/day, rich in essential amino acids (primarily leucine) is crucial to maintaining positive protein balance in musculoskeletal tissue. While we acknowledge the importance of high protein intake in older adults, we will not elaborate on this topic, given the extensive international and governmental efforts already in place. For example, the ESPEN Expert Group (7) and the PROT-AGE Study Group (8) provide international guidelines, while governmental initiatives such as the World Health Organization's 'Keep fit for life: meeting the nutritional needs of older persons' (9) and the European Commission's 'Dietary recommendations for protein intake for adults and older adults' (10) address this issue comprehensively.In this opinion article, we advocate for the combination of creatine monohydrate supplementation and resistance training as a safe and effective non-pharmacological strategy to prevent and treat sarcopenia that should be internationally recognized by health practitioners and public health organizations.Creatine (Cr) is derived from reactions involving amino acids in the liver and brain. Approximately 95% of the Cr creatine pool in the body is found in skeletal muscle, while 5% is found in other tissues with high energy demands such as cardiomyocytes, hepatocytes, kidney cells, inner ear cells, enterocytes, spermatozoa, and photoreceptor cells. Creatine in its phosphorylated form, phosphocreatine (PCr), plays a pivotal role in sustaining adenosine triphosphate (ATP) in these cells (11).Creatine is naturally present in meat, fish, and poultry with an estimated daily requirement of approximately 2 g•day -1 for a 70-kg male to maintain normal creatine levels in the human body (12,13). Notwithstanding, research across diverse populations has demonstrated that endogenous creatine synthesis may be insufficient under numerous physiological and pathological conditions (14).Following the groundbreaking research of Dr. Roger Harris in 1992 (15), creatine monohydrate became widely available as a dietary supplement in the United States and Europe, fully compliant with the U.S. Food and Drug Administration (FDA) regulations. Given its natural presence in food and its availability as a supplement before October 15, 1994, creatine was grandfathered under the Dietary Supplement Health and Education Act (DSHEA) as a legal dietary supplement in the U.S. Recently, the FDA expressed no objections to a Generally Recognized as Safe (GRAS) application, permitting the inclusion of creatine monohydrate as a food additive in various food products (GRAS Notice 931) (16). Further, after consultation on novel food status under Regulation (EU) 2015/2283, creatine is not considered a novel food as creatine monohydrate has been used for human consumption to a significant degree in the European Union before 15 May 1997 (17). Creatine is approved for inclusion in dietary supplements and/or food products in numerous countries, including Canada, Australia, the European Union, Japan, South Korea, and Brazil, among others (18). Extensive research, including randomized, double-blind, placebo-controlled clinical trials, have consistently demonstrated that creatine monohydrate supplementation is both safe and effective in humans (12,19,20), including older adults (21,22). Thus, there is a strong consensus within the scientific community that creatine monohydrate supplementation (e.g., 20 grams/day or 0.3 grams/kg/day for 5-7 days; 3-5 grams/day or 0.03 grams/kg/day; or 0.1-0.14 grams/kg/day) can safely and effectively enhance exercise performance capacity and training adaptations in both untrained and trained individuals, regardless of exercise interventions, biological sex or age (12,19,(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38).Research across diverse populations has demonstrated that -Abstract Truncated-
physiology